Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 3 (1)

Trial Status

Recruiting1
Not Yet Recruiting1
Active Not Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT02399527Recruiting

Lymphatic Anomalies Registry for the Assessment of Outcome Data

NCT06642051Not ApplicableActive Not Recruiting

Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery

NCT07285005Phase 3Not Yet Recruiting

A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

Showing all 3 trials

Research Network

Activity Timeline